课题基金 / 基金详情

Paracrine and autocrine IL-6 as drivers of treatment resistance in medulloblastoma

Paracrine and autocrine IL-6 as drivers of treatment resistance in medulloblastoma
旁分泌和自分泌 IL-6 作为髓母细胞瘤治疗抵抗的驱动因素
批准号:
468060
负责人:
Lim Chinten J
金额:
$4.37万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-02-01 至 2024-02-01

项目摘要

项目成果

Lim Chinten J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Brain tumors represent the deadliest forms of childhood cancers. Owing to its location within the cortex of the still developing brain, complete tumor removal by resection is often not achieved. Thus, the mainstay for treatment remains chemo and radiation
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting CD47 in pediatric acute lymphoblastic leukemia.
Integrin signaling in cell adhesion mediated drug resistance in pediatric acute leukemias.
Integrin alpha4 cytoplasmic domain signaling in cell adhesion and chemoresistance.
海外基金